New Hope and Future Directions
Ovarian Cancer Symposium
Sunday, August 15, 2010
Sheraton Grand Hotel, Sacramento, CA
Register Now!!
The California Ovarian Cancer
Awareness Program is hosting Teal Impact 2010, an ovarian cancer symposium scheduled for Sunday, August 15th,
2010 at the Sheraton Grand Hotel in Sacramento California. This symposium is being planned in collaboration with the
Public Health Institute and several other community-based organizations.
Topics
The theme of the symposium is new hope and future directions. The topics
include research, clinical trials and molecular profiling. In addition, there will be a component that highlights best
practices of community-based organizations for their work in various ovarian cancer efforts. This session will allow
participants the opportunity to glean useful information to take back to their own communities for replication. The
California Office of Women’s Health will also give a presentation on the important Gynecologic Cancer Information Program.
Objectives
This symposium will enable
participants to:
· Learn about the
symptoms of ovarian cancer.
·
Learn about current and emerging ovarian cancer research issues and findings.
·
Learn the importance of clinical trials in the advancement of ovarian cancer
prevention, diagnosis and treatment.
· Discover new opportunities
for networking with those interested in ovarian cancer research, education and survivorship.
Target Audience
The target audiences for this symposium are healthcare professionals,
researchers, ovarian cancer survivors, public health practitioners and individuals and organizations
concerned about ovarian cancer issues across the state.
Confirmed Speakers
Afshin Bahador, MD
South
Coast Gynecologic Oncology, Inc.
Dr. Bahador is a board-certified obstetrician and gynecologist with subspecialty
board certification in gynecologic oncology. He received his medical degree from the University of Southern California (USC)
School of Medicine and residency in obstetrics and gynecology at Los Angeles County (LAC) - USC Medical Center. He also
completed his fellowship in gynecologic oncology at LAC - USC Medical Center. Dr. Bahador has been named a “Top
Doctor” by San Diego Magazine in 2006, 2007, 2008 and 2009. He is currently practicing in San Diego, CA, where
he specializes in the most advanced and up-to-date therapeutic options for gynecologic malignancies. Dr. Bahador is
also considered a leader in minimally invasive and robotic surgery.
Cyllene Morris, DVM, PhD
California Cancer
Registry
Dr. Morris is an epidemiologist with over fifteen years of experience in surveillance research within
the California Cancer Registry (CCR). She earned her DVM degree from the University of Sao Paulo, Brazil, a master's
degree in preventive veterinary medicine, and a PhD in epidemiology, both from the University of California at Davis.
Dr. Morris received a New Investigator's Award from the California Breast Cancer Research Program, and has authored many studies
and special reports on disparities in cancer treatment and diagnosis.
University of California, Davis
Dr. Rodriguez is currently
Associate Professor of Obstetrics and Gynecology at the University of California, Davis, School of Medicine. She received
her medical and undergraduate degrees with honors at Northwestern University and completed her residency in Obstetrics and
Gynecology at the University of North Carolina at Chapel Hill. She completed a three year fellowship in Gynecologic Oncology
at the University of Miami/ Jackson Memorial Hospital. Dr Rodriguez maintains an active clinical practice in gynecologic
oncology, is fellowship program director for the UC Davis fellowship in gynecologic oncology and is active in multiple research
endeavors. She has a special interest in complementary medicine and is trained in medical acupuncture.
Sidney A. Scudder, MD
University of California,
Davis
Dr. Scudder directs the
Infusion Center at UC Davis Cancer Center. His interests lie in the treatment of gynecologic malignancies, especially ovarian
and cervical cancer, and in concurrent chemotherapy and radiation therapy for these diseases. He participates in basic and
translational research with an emphasis on pharmacology and new drug development.
Deborah Zajchowski, PhD
The Clearity Foundation
Dr. Zajchowski, PhD is
a cancer biologist with over 20 years experience in cancer research and drug discovery in the biopharmaceutical industry.
She is also president of Oncology Consulting Services and provides clients with cancer biology/ functional genomics guidance
for biomarker, target, and drug discovery/ evaluation.
